Armistice Capital »

Credit Acceptance shares owned by Armistice Capital

Quarter-by-quarter ownership of Credit Acceptance (CACC) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in Credit Acceptance

Tip: Access up to 7 years of quarterly data

All positions including Credit Acceptance held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Credit Acceptance by Armistice Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $449k 1.1k 423.46

More positions owned by Armistice Capital

State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Agios Pharmaceuticals (AGIO)
Cytokinetics Com New (CYTK)
Ptc Therapeutics I (PTCT)
Travere Therapeutics (TVTX)
Madrigal Pharmaceuticals (MDGL)
Immunovant (IMVT)
Supernus Pharmaceuticals (SUPN)
Neurocrine Biosciences (NBIX)
Freshpet (FRPT)
Incyte Corporation (INCY)
Dyne Therapeutics (DYN)
Amazon (AMZN)
Ironwood Pharmaceuticals Com Cl A (IRWD)

View all positions for Armistice Capital

Top funds holding Credit Acceptance

Prescott General Partners
Robeco Investment Management
Ruane, Cunniff & Goldfarb
Vanguard Group
Gobi Capital
Beck Mack & Oliver
Limestone Investment Advisors
Wellington Management Company
BlackRock
Universal- Beteiligungs- und Servicegesellschaft mbH
Dimensional Fund Advisors
Vanguard Capital Management
Smead Capital Management
Vanguard Portfolio Management
RV Capital GmbH

View all funds holding Credit Acceptance